<!doctype html>
<html lang="en">
<head>
  <meta charset="utf-8" />
  <meta name="viewport" content="width=device-width, initial-scale=1" />
  <title>Atrial fibrillation (new diagnosis + anticoagulation) — DGRefHelp Drafts</title>
  <link rel="stylesheet" href="../assets/site.css" />
</head>
<body>
  <div class="container">
    <div class="header">
      <div class="brand">
        <h1><a href="../index.html">DGRefHelp drafts</a> / Atrial fibrillation (new diagnosis + anticoagulation)</h1>
        <div class="sub">Adults with newly diagnosed AF: confirm on 12‑lead ECG, assess stability, reduce stroke risk using CHA2DS2‑VASc + bleeding risk (ORBIT), and initiate DOACs where locally agreed.</div>
      </div>
      <div class="badges">
        <div class="badge">Mode: quick</div>
        <div class="badge">Last updated: 2026‑02‑10</div>
      </div>
    </div>

    <div class="grid">
      <div class="card">
        <div class="card-hd">
          <div class="tabs" data-tabs>
            <button class="tab" role="tab" data-tab="evidence" aria-selected="true">Evidence</button>
            <button class="tab" role="tab" data-tab="draft" aria-selected="false">DGRefHelp draft</button>
            <button class="tab" role="tab" data-tab="refs" aria-selected="false">References</button>
          </div>
          <div class="copybar">
            <button class="btn" data-copy-target="#draftText">Copy draft</button>
            <button class="btn" data-copy-target="#evidenceText">Copy evidence</button>
          </div>
        </div>

        <div class="card-bd">
          <div class="panel active" role="tabpanel" data-panel="evidence">
            <div id="evidenceText" class="section">
<h3>Evidence summary (triangulated)</h3>

              <div class="callout ok">
                <strong>Key design points (primary care)</strong>
                <ul>
                  <li>For suspected AF: <strong>confirm with a 12‑lead ECG</strong> if an irregular pulse is detected (NICE NG196).</li>
                  <li><strong>Stroke prevention decisions</strong> should use <strong>CHA2DS2‑VASc</strong> for stroke risk assessment (NICE NG196).</li>
                  <li><strong>Bleeding risk</strong>: NICE NG196 recommends <strong>ORBIT</strong> (higher accuracy for absolute bleeding risk prediction than other tools). Use it to support shared decision making and to drive <strong>risk factor modification</strong> (e.g. uncontrolled HTN; interacting meds; alcohol; anaemia).</li>
                  <li><strong>Anticoagulation thresholds (NICE NG196)</strong>:
                    <ul>
                      <li><strong>Offer</strong> anticoagulation (DOAC) if <strong>CHA2DS2‑VASc ≥2</strong>.</li>
                      <li><strong>Consider</strong> anticoagulation (DOAC) for <strong>men</strong> with <strong>CHA2DS2‑VASc = 1</strong>.</li>
                      <li><strong>Do not</strong> anticoagulate people &lt;65 with no risk factors other than sex (CHA2DS2‑VASc 0 for men or 1 for women).</li>
                      <li><strong>Do not</strong> withhold anticoagulation solely because of <strong>age</strong> or <strong>falls risk</strong>.</li>
                    </ul>
                  </li>
                  <li>NICE NG196 recommends <strong>DOACs first line</strong> for eligible people. If DOACs are contraindicated/not suitable, offer a <strong>vitamin K antagonist</strong>.</li>
                </ul>
            </div>
          </div>

          <div class="panel" role="tabpanel" data-panel="draft">

            <div class="callout" style="margin-bottom:12px">
              <strong>Copy/paste HTML for Right Decisions accordion sections</strong>
              <div class="small">Per your preference, these snippets contain section content only (no internal headings). Paste each into the matching accordion section.</div>
              <div style="height:10px"></div>
              <div class="copybar" style="justify-content:flex-start">
                <button class="btn" data-copy-target="#htmlBackground">Copy Background HTML</button>
                <button class="btn" data-copy-target="#htmlAssessment">Copy Assessment HTML</button>
                <button class="btn" data-copy-target="#htmlPCM">Copy Primary care mgmt HTML</button>
                <button class="btn" data-copy-target="#htmlRefer">Copy Who to refer HTML</button>
                <button class="btn" data-copy-target="#htmlNotRefer">Copy Who not to refer HTML</button>
                <button class="btn" data-copy-target="#htmlRefs">Copy References HTML</button>
              </div>

              <details style="margin-top:10px">
                <summary class="small" style="cursor:pointer">Show HTML snippets</summary>

                <h4 style="margin:12px 0 6px">Background (HTML)</h4>
                <pre id="htmlBackground">&lt;ul&gt;&lt;li&gt;(Add 1–3 background bullets if desired.)&lt;/li&gt;&lt;/ul&gt;</pre>

                <h4 style="margin:12px 0 6px">Assessment (primary care) (HTML)</h4>
                <pre id="htmlAssessment">&lt;ul&gt;
                &lt;li&gt;&lt;strong&gt;Haemodynamic instability&lt;/strong&gt;: hypotension/shock, acute pulmonary oedema, ongoing syncope, chest pain suggestive of ACS, new severe breathlessness/hypoxia.&lt;/li&gt;
                &lt;li&gt;&lt;strong&gt;Very fast ventricular rate&lt;/strong&gt; with concerning symptoms (use local thresholds) OR suspected &lt;strong&gt;ventricular tachycardia&lt;/strong&gt; / broad complex tachycardia.&lt;/li&gt;
                &lt;li&gt;&lt;strong&gt;Stroke/TIA symptoms&lt;/strong&gt; → emergency stroke pathway.&lt;/li&gt;
              &lt;/ul&gt;</pre>

                <h4 style="margin:12px 0 6px">Primary care management (HTML)</h4>
                <pre id="htmlPCM">&lt;ul&gt;&lt;li&gt;See assessment and referral sections. Add local management steps if needed.&lt;/li&gt;&lt;/ul&gt;</pre>

                <h4 style="margin:12px 0 6px">Who to refer (HTML)</h4>
                <pre id="htmlRefer">&lt;ul&gt;&lt;li&gt;(Add referral destinations + urgency.)&lt;/li&gt;&lt;/ul&gt;</pre>

                <h4 style="margin:12px 0 6px">Who not to refer (HTML)</h4>
                <pre id="htmlNotRefer">&lt;ul&gt;&lt;li&gt;(If no explicit ‘who not to refer’ applies, omit or keep minimal.)&lt;/li&gt;&lt;/ul&gt;</pre>

                <h4 style="margin:12px 0 6px">References (HTML)</h4>
                <pre id="htmlRefs">&lt;ol&gt;&lt;li&gt;(Add references here.)&lt;/li&gt;&lt;/ol&gt;</pre>
              </details>
            </div>

            <div id="draftText" class="section">
<h3>Atrial fibrillation — new diagnosis + anticoagulation (adults)</h3>

              <h4>Immediate triage (999 / ED now)</h4>
              <ul>
                <li><strong>Haemodynamic instability</strong>: hypotension/shock, acute pulmonary oedema, ongoing syncope, chest pain suggestive of ACS, new severe breathlessness/hypoxia.</li>
                <li><strong>Very fast ventricular rate</strong> with concerning symptoms (use local thresholds) OR suspected <strong>ventricular tachycardia</strong> / broad complex tachycardia.</li>
                <li><strong>Stroke/TIA symptoms</strong> → emergency stroke pathway.</li>
              </ul>

              <h4>Confirm diagnosis</h4>
              <ul>
                <li>If an <strong>irregular pulse</strong> is detected and AF suspected: perform a <strong>12‑lead ECG</strong> to diagnose AF (NICE NG196).</li>
                <li>If AF suspected but not seen and episodes are intermittent: arrange <strong>ambulatory ECG monitoring</strong> chosen by symptom frequency (see Palpitations page / NICE NG196).</li>
              </ul>

              <h4>Initial assessment (aim: stability + reversible contributors + baseline for safe anticoagulation)</h4>
              <ul>
                <li><strong>Observations:</strong> HR, BP, RR, Temp, <strong>SpO2 on air</strong>.</li>
                <li><strong>History:</strong> onset/time of onset if known; symptoms (chest pain, breathlessness, presyncope/syncope); stroke/TIA history; heart failure/valve disease; bleeding history; alcohol; interacting medicines (NSAIDs, antiplatelets, SSRIs).</li>
                <li><strong>Examination:</strong> heart failure signs; murmurs (valvular disease); volume status.</li>
                <li><strong>Baseline tests (typical):</strong> FBC (anaemia/platelets), U&amp;Es/eGFR, LFTs, TFTs; glucose/HbA1c/lipids per cardiovascular risk work; consider magnesium if acutely unwell.</li>
                <li><strong>Echocardiography:</strong> do <strong>TTE</strong> if important for long-term management, rhythm-control strategy, or suspected structural heart disease (NICE NG196). Do not do TTE solely to further stroke-risk stratify if anticoag decision already agreed (NICE NG196).</li>
              </ul>

              <h4>Stroke risk assessment (CHA2DS2‑VASc)</h4>
              <ul>
                <li>Use <strong>CHA2DS2‑VASc</strong> for stroke risk in AF/atrial flutter/paroxysmal/persistent/permanent, including post-cardioversion/ablation recurrence risk (NICE NG196).</li>
                <li>Document the components in the record and referral letter (so it’s auditable).</li>
              </ul>

              <h4>Bleeding risk assessment (ORBIT) + modify risk</h4>
              <ul>
                <li>Assess bleeding risk when starting or reviewing anticoagulation using <strong>ORBIT</strong> (NICE NG196).</li>
                <li>Actively modify bleeding risks where possible (NICE NG196), e.g.:
                  <ul>
                    <li><strong>Uncontrolled hypertension</strong>.</li>
                    <li><strong>Interacting drugs</strong> (antiplatelets, NSAIDs, SSRIs) — review necessity.</li>
                    <li><strong>Alcohol</strong> (harmful use) — address.</li>
                    <li><strong>Anaemia</strong> — investigate reversible causes.</li>
                  </ul>
                </li>
              </ul>

              <h4>Anticoagulation decision (NICE NG196)</h4>
              <ul>
                <li><strong>Offer</strong> anticoagulation with a <strong>DOAC</strong> if <strong>CHA2DS2‑VASc ≥2</strong>, taking bleeding risk into account.</li>
                <li><strong>Consider</strong> anticoagulation with a <strong>DOAC</strong> for <strong>men</strong> with <strong>CHA2DS2‑VASc = 1</strong>, taking bleeding risk into account.</li>
                <li><strong>Do not</strong> offer anticoagulation for people &lt;65 with no risk factors other than sex (CHA2DS2‑VASc 0 men / 1 women).</li>
                <li><strong>Do not</strong> withhold anticoagulation solely because of <strong>age</strong> or <strong>falls risk</strong>.</li>
                <li>If DOACs are contraindicated/not tolerated/not suitable: offer a <strong>vitamin K antagonist</strong> (NICE NG196).</li>
              </ul>

              <div class="callout warn">
                <strong>Practical safety notes (non-prescriptive)</strong>
                <div class="small">
                  For DOAC prescribing, ensure you have an up-to-date weight and renal function, check for interacting medicines, and choose the correct dose (renal impairment/age/weight criteria differ by agent). Use local medicines guidance/BNF/MHRA advice.
            </div>
          </div>

          <div class="panel" role="tabpanel" data-panel="refs">
            <div class="section">
              <h3>References (retrieved 2026‑02‑06)</h3>
              <ol>
                <li>RCOG Green‑top Guideline No. 34: Ovarian Cysts in Postmenopausal Women (consensus update Dec 2025; web page last reviewed 05 Dec 2025). <a href="https://www.rcog.org.uk/guidance/browse-all-guidance/green-top-guidelines/ovarian-cysts-in-postmenopausal-women-green-top-guideline-no-34/">rcog.org.uk</a></li>
                <li>NICE NG12: Suspected cancer — recommendations organised by site of cancer (ovarian cancer section; CA‑125 ≥35 → USS). <a href="https://www.nice.org.uk/guidance/ng12/chapter/Recommendations-organised-by-site-of-cancer">nice.org.uk</a></li>
                <li>Right Decisions (GGC primary care): Ovarian cysts in post-menopausal women (example of local thresholds/RMI approach; not D&amp;G). <a href="https://www.rightdecisions.scot.nhs.uk/ggc-primary-care/womens-health/gynaecology-clinical-guidelines/ovarian-cysts-in-post-menopausal-women-549/">rightdecisions.scot.nhs.uk</a></li>
              </ol>
            </div>
          </div>

        </div>
      </div>

      <div class="footer">
        <a href="../index.html">← Back to topics</a>
      </div>
    </div>
  </div>

  <script src="../assets/site.js"></script>
</body>
</html>
